2025-12-06 - Analysis Report
Okay, here's a comprehensive report on Albemarle Corp (ALB), based on the data you provided.

**1) Return Rate Comparison**

*   **Albemarle Corp (ALB) Overview:** Albemarle Corp. is a specialty chemicals company with leading positions in lithium, bromine specialties, and catalysts.
*   **ALB Cumulative Return:** 21.91%
*   **S&P 500 (VOO) Cumulative Return:** 100.58%
*   **Divergence:** -78.67 (ALB underperformed the S&P 500)
*   **Relative Divergence:** 14.2

**Analysis of Alpha, Beta, and Performance Metrics:**

| Year       | CAGR     | MDD      | Alpha   | Beta   | Cap(B) |
|------------|----------|----------|---------|--------|--------|
| 2015-2017  | 85.0%    | 68.0%    | 56.0%   | 0.1    | 14.9   |
| 2016-2018  | 9.0%     | 68.0%    | -6.0%   | 0.0    | 9.0    |
| 2017-2019  | -44.0%   | 73.9%    | -66.0%  | 0.1    | 8.5    |
| 2018-2020  | 44.0%    | 79.4%    | 20.0%   | 0.2    | 17.2   |
| 2019-2021  | 149.0%   | 79.4%    | 103.0%  | -0.1   | 27.2   |
| 2020-2022  | 148.0%   | 79.9%    | 149.0%  | 0.5    | 25.3   |
| 2021-2023  | -26.0%   | 81.9%    | -27.0%  | 0.5    | 16.8   |
| 2022-2024  | -152.0%  | 81.9%    | -172.0% | 0.3    | 10.0   |
| 2023-2025  | -199.0%  | 81.9%    | -265.0% | -0.9   | 14.7   |

*   **CAGR:**  The Compound Annual Growth Rate shows periods of very high growth (e.g., 2015-2017, 2019-2022) followed by significant declines more recently. The last few periods have been sharply negative.
*   **MDD:** The Maximum Drawdown indicates substantial risk, with MDDs consistently high. This suggests significant volatility in ALB's stock price.
*   **Alpha:** Alpha measures the stock's performance relative to the market (S&P 500).  ALB has periods of strong outperformance (high positive Alpha) but also periods of significant underperformance (large negative Alpha). Recent Alphas are very negative, indicating substantial underperformance.
*   **Beta:** Beta measures the stock's volatility relative to the market. Betas close to 0 or even negative from 2019 to 2021 suggest that ALB's price movements have not been strongly correlated with the broader market recently.
*   **Cap(B):** Market capitalization indicates the size of the company during those period.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 126.49
*   **Last Market Data:**  Price: 125.20, Previous Close: 119.14, Change: +5.08
*   **5-day SMA:** 127.50
*   **20-day SMA:** 115.23
*   **60-day SMA:** 97.73

**Analysis:** The stock price is above its 20-day and 60-day moving averages, suggesting upward momentum. The 5-day SMA is slightly above the current close, indicating a possible short-term pullback. The significant change in the last market data reflects strong recent upward price movement.

**3) Indicators Analysis**

*   **MRI (Market Risk Indicator):** 0.8 (Medium Investment Recommended)
*   **RSI:** 67.16 (Approaching overbought territory)
*   **PPO:** 0.1358
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** 1.3 (+): 단기상승 (Short-term rise)
*   **Expected Return:** 118.1% (Long-term, >2 years)

**Analysis:** The MRI suggests a medium level of investment risk. The RSI approaching 70 indicates the stock may be overbought, potentially signaling a future price correction. The positive change in relative divergence over the last 20 days suggests a short-term upward trend. The high Expected Return should be taken with caution, as it assumes long-term investment and may not materialize given the company's recent performance.

**4) Recent News & Significant Events**

*   **Positive Sentiment:** Recent news headlines are largely positive. Several articles highlight analyst upgrades (UBS), price target increases (Baird, Quiver Quantitative), and lithium market optimism.
*   **Stock Performance:** Articles note a recent rally in Albemarle's stock price.
*   **Trefis Article:** Cautions that a recent jump in Albemarle Stock "Looks Great, But How Secure Is That Gain?".

**Analysis:** Recent news suggests a positive shift in sentiment towards Albemarle, driven by optimism in the lithium market. However, it's important to note the cautionary Trefis article which questions the sustainability of recent gains.

**4-2) Analyst Opinions**

*   **Consensus:** Hold
*   **Mean Recommendation:** 2.58 (~Hold)
*   **Target Price Range:** 58.00 - 200.00
*   **Average Target Price:** 111.53

**Analysis:** The analyst consensus is a "Hold" rating, suggesting a neutral outlook. The wide target price range indicates uncertainty among analysts regarding Albemarle's future performance. The average target price of 111.53 is below the current price, suggesting potential downside risk, though positive outlooks also exist with the high target of 200.00.

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue   |
|------------|------|-----------|
| 2025-11-05 | -1.72| 1.31 B$   |
| 2025-08-04 | -0.16| 1.33 B$   |
| 2025-04-30 | 0    | 1.08 B$   |
| 2024-11-06 | -9.45| 1.35 B$   |
| 2025-11-05 | -9.45| 1.35 B$   |

**Analysis:** Recent EPS figures are mostly negative, indicating losses. While revenue has been relatively stable (around $1.3B), the negative EPS raises concerns about profitability.

**6) Financial Information:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30   | $1.31B  | 8.99%         |
| 2025-06-30   | $1.33B  | 14.80%        |
| 2025-03-31   | $1.08B  | 14.51%        |
| 2024-12-31   | $1.23B  | 11.22%        |
| 2024-09-30   | $1.35B  | -7.68%        |

| Quarter      | Equity    | ROE       |
|--------------|-----------|-----------|
| 2025-09-30   | $10.00B   | -1.61%    |
| 2025-06-30   | $10.24B   | 0.22%     |
| 2025-03-31   | $10.03B   | 0.41%     |
| 2024-12-31   | $9.96B    | 0.76%     |
| 2024-09-30   | $10.24B   | -10.44%   |

**Analysis:**

*   **Revenue:** Revenue is generally stable but varies somewhat quarter to quarter.
*   **Profit Margin:** Profit margins have fluctuated significantly.  A negative profit margin in 2024-09-30 indicates a period of unprofitability.
*   **Equity:** Equity has remained relatively stable.
*   **ROE:** ROE (Return on Equity) has been generally low and even negative, showing inefficient use of equity to generate income.

**7) Comprehensive Analysis (Summary)**

Albemarle (ALB) is experiencing a mixed situation.

*   **Underperformance:**  ALB has significantly underperformed the S&P 500 in terms of cumulative return.
*   **Volatile Performance:** The company has seen periods of very high growth and significant declines, reflected in its historical CAGR, MDD, and Alpha figures.
*   **Recent Positive Momentum:**  The stock has recently shown positive momentum, reflected in its price relative to its moving averages and recent news headlines.
*   **Analyst Uncertainty:**  Analyst opinions are mixed, with a consensus "Hold" rating and a wide target price range.
*   **Earnings Concerns:**  Recent earnings have been negative, raising concerns about profitability.
*   **Lithium Market Driver:**  Positive sentiment is driven by optimism in the lithium market. However, the security of recent gains has been questioned.
*   **Financial Metrics:** fluctuating revenues, unstable profit margins, and fluctuating equity and ROE levels

**Conclusion:**

ALB presents a complex picture for investors. While recent positive momentum and lithium market optimism might be appealing, the company's historical volatility, recent underperformance, negative earnings, and analyst uncertainty warrant caution. Further research into the long-term outlook for the lithium market and Albemarle's specific strategies for improving profitability is recommended before making any investment decisions.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.